Vor Ort
Merkzettel Warenkorb
  • Produktbild: Blood Replacement
  • Produktbild: Blood Replacement

Blood Replacement

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.01.1969

Verlag

Springer Berlin

Seitenzahl

284

Maße (L/B/H)

23,5/15,5/1,7 cm

Gewicht

575 g

Auflage

Softcover reprint of the original 1st ed. 1969

Übersetzt von

L. Oxtoby + weitere

Sprache

Englisch

ISBN

978-3-540-04496-3

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.01.1969

Verlag

Springer Berlin

Seitenzahl

284

Maße (L/B/H)

23,5/15,5/1,7 cm

Gewicht

575 g

Auflage

Softcover reprint of the original 1st ed. 1969

Übersetzt von

  • L. Oxtoby
  • R.F. Armstrong

Sprache

Englisch

ISBN

978-3-540-04496-3

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Kundinnen und Kunden meinen

0 Bewertungen

Informationen zu Bewertungen

Zur Abgabe einer Bewertung ist eine Anmeldung im Konto notwendig. Die Authentizität der Bewertungen wird von uns nicht überprüft. Wir behalten uns vor, Bewertungstexte, die unseren Richtlinien widersprechen, entsprechend zu kürzen oder zu löschen.

Die Bewertungen sind nach Format, Anzahl Sterne und Datum sortiert.

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kund*innen durch Ihre Meinung

Kundinnen und Kunden meinen

0 Bewertungen filtern
  • Produktbild: Blood Replacement
  • Produktbild: Blood Replacement
  • one: Pathophysiology of Blood Loss.- A. Pathophysiology of Hemorrhagic Shock.- B. Spontaneous Regulation Processes of the Organism Following Blood Loss.- I. Losses of 500–1000 ml of Blood.- II. Larger Blood Losses.- C. Problems of Oxygen Transport.- I. Rest Conditions.- II. Jeopardy of Adequate Oxygen Supply.- III. Necessity of Erythrocyte Replacement.- IV. Evaluation of the Oxygen Supply of the Body.- V. Flow Properties of Blood.- VI. To what Extent May the Blood Volume be Replaced with Erythrocyte-free Solutions?.- D. Summary and Conclusions: Pathophysiology of Blood Loss.- TWO: Various Methods of Volume Replacement.- A. Volume Replacement Using Blood.- I. Disadvantages and Dangers of Blood Transfusion.- 1. Mortality.- 2. The Transmission of Disease.- a) The Frequency of Transfusion Hepatitis.- b) Mortality of Transfusion Hepatitis.- c) Measures for Preventing Transfusion Hepatitis.- 3. Reactions due to Bacterial Contamination.- 4. Incompatibility.- 5. Hemolytic Reactions.- 6. Allergic Reactions.- 7. Citrate Toxicity.- 8. Acidity of Preserved Blood.- 9. Temperature Drop after Addition of Larger Amounts of Cold Blood.- 10. Blood Coagulation Disturbances after Massive Blood Transfusions.- 11. Potassium Intoxication.- 12. Ammonia Intoxication.- 13. Post-transfusion Hyperbilirubinemia.- 14. Various other Factors.- 15. Reduction of Bacterial Resistance.- 16. Impairment of the Flow Properties of Blood.- 17. Survival of Transfused Erythrocytes.- II. The Volume Effect of Blood Transfusions — Therapeutic Results.- III. Summary and Conclusions: Volume Replacement with Blood.- B. Volume Replacement with Plasma.- I. The Various Plasma Preparations.- 1. Fresh Plasma.- 2. Pooled Plasma (Aged Plasma, Normal, Whole) Stored at 32° C.- 3. Human Dried Plasma = HDP.- 4. Pasteurized Plasma Protein Solution = PPS.- 5. Albumin.- II. The Volume Effect of Plasma.- 1. Fresh Plasma.- 2. Stored Pooled Plasma.- 3. Dried Plasma.- 4. Pasteurized Plasma Protein Solution.- 5. Albumin.- III. Therapeutic Results.- IV. Summary and Conclusions: Volume Replacement with Plasma.- C. Volume Replacement with Artificial Colloid-Containing Infusion Solutions.- I. Introduction.- II. Terminology.- III. The Requirements for Artificial Colloid-Containing Infusion Solutions.- IV. Physico-chemical Characterization of Artificial Colloids.- 1. Molecular Weight.- 2. Viscosity.- V. The Various Artificial Colloids.- 1. Dextran.- a) Definition.- b) General Preliminary Remarks for Evaluating Literature on Dextran.- c) The Various Dextran Preparations.- d) Compatibility of Macrodex and Rheomacrodex with Medications.- e) Colloid Osmotic Pressure and Effect, Water Retaining Capacity.- f) Metabolism.- g) Plasma Concentration, Excretion in Urine, Renal Function.- h) Histological Investigations.- i) Immunological Investigations.- k) Allergic Reactions.- l) Influence on Sedimentation Rate, Aggregating and Disaggregating Properties 7% m) Influence on Viscosity.- n) Influence upon Blood Group Determination 82 o) Influence upon Defence against Infection and Nonspecific Resistance.- p) Carcinogenicity.- q) Influence upon Blood Coagulation.- r) Pharmacological Properties.- s) Influence on Laboratory Investigations.- t) Stability During Storage.- u) The Volume Effect of Dextran.- v) Hemodynamics.- w) Therapeutic Results.- x) Summary and Conclusions: Volume Replacement with Dextran.- 2. Gelatin.- a) Definition.- b) General Remarks Concerning Evaluation of Gelatin Literature.- c) The Various Gelatin Preparations.- d) Compatibility of Gelatin Preparations with Medications.- e) Colloid Osmotic Pressure and Effect, Water Retaining Capacity.- f) Metabolism.- g) Plasma Concentrations, Excretion in Urine, Renal Function.- h) Histological Studies.- i) Immunological Studies.- k) Allergic Reactions.- l) Influence on Sedimentation Rate, Aggregating and Disaggregating Properties.- m) Influence on Viscosity.- n) Influence on Blood Group Determination.- o) Influence upon Defence against Infection and Nonspecific Resistance.- p) Carcinogenicity.- q) Influence on Blood Coagulation.- r) Pharmacological Properties.- s) Stability during Storage.- t) The Volume Effect of Gelatin.- u) Hemodynamics.- v) Therapeutic Results.- w) Summary and Conclusions: Volume Replacement with Gelatin.- 3. Polyvinyl Pyrrolidone (PVP).- a) Definition.- b) The Various Preparations.- c) Metabolism.- d) Volume Effect.- e) Summary: Polyvinyl Pyrrolidone.- 4. Starch (Hydroxyethyl Starch).- a) Definition.- b) Manufacture.- c) Metabolism.- d) Plasma Concentration.- e) Renal Function.- f) Histological Investigations.- g) Influence on Blood Coagulation.- h) Immunological Studies.- i) Influence on Sedimentation Rate.- k) Pharmacological Properties.- l) Volume Effect.- m) Therapeutic Results.- n) Summary: HO-ethyl Starch.- 5. Alginon.- 6. Levan.- D. Volume Replacement with Colloid-free Solutions.- Three: Discussion.- A. Oral Therapy.- B. Intra-arterial Infusion.- C. Hemoglobin, Oxygen Transport.- I. The Gas Phase.- II. The Blood Phase.- III. The Tissue Phase.- D. Shock Models.- E. Problems of Blood Volume Determination.- F. Colloid Osmotic Pressure, Filtration, Interstitial Pressure.- G. Comparison of the Various Possibilities which are Available for Replacement of Blood Loss.- H. Dextran or Gelatin?.- I. Practical Conclusions.- J. Concluding Remarks.- K. Outlook.- FOUR: Summary.- Literature.- Additional Literature.- Appendix to the Literature.